Bilirubinometer

Bilirubinometer Market Outlook

The global bilirubinometer market is projected to reach approximately USD 300 million by 2030, growing at a CAGR of about 6.5% during the forecast period from 2025 to 2030. The increasing prevalence of neonatal jaundice, particularly in developing regions, is one of the primary growth drivers for this market. Additionally, the rising awareness regarding early diagnosis and the importance of timely treatment for conditions associated with elevated bilirubin levels is propelling market growth. Technological advancements in bilirubin measurement devices, including the development of noninvasive and portable units, are also contributing significantly to market expansion. Furthermore, the growing healthcare infrastructure and increased investments in neonatal care facilities across various regions are expected to bolster the demand for bilirubinometers.

Growth Factor of the Market

The bilirubinometer market is experiencing robust growth due to several interlinked factors that are enhancing its reach and utility. First and foremost, the increasing incidence of jaundice among newborns, which affects nearly 60% of term infants and 80% of preterm infants, is a significant contributor to market growth. This has prompted healthcare providers to invest in advanced diagnostic tools that enable timely intervention. Moreover, rising awareness among healthcare professionals and parents about the importance of detecting and managing jaundice early is fostering an environment conducive to market expansion. The emergence of advanced technologies, such as smart bilirubinometers equipped with AI capabilities for accurate measurements, is transforming traditional practices. Furthermore, government initiatives promoting neonatal health and screening programs serve to boost the demand for bilirubin measurement devices. Lastly, the expansion of healthcare facilities, especially in low- and middle-income countries, is expected to create new opportunities for market players.

Key Highlights of the Market

• The global bilirubinometer market is projected to grow at a CAGR of 6.5% from 2025 to 2030.
• Increasing prevalence of neonatal jaundice is driving the demand for bilirubinometers.
• Technological advancements are leading to the development of noninvasive and portable bilirubinometers.
• Government initiatives aimed at improving neonatal health are facilitating market growth.
• The expansion of healthcare facilities globally is creating new opportunities for market players.

By Product Type

Transcutaneous Bilirubinometer:

The transcutaneous bilirubinometer is a non-invasive device that measures bilirubin levels through the skin, making it a popular choice in neonatology. This type of bilirubinometer uses light to assess the bilirubin concentration in the skin, providing quick results without the need for blood tests. The advantage of using transcutaneous methods is primarily associated with their ease of use and reduced distress for infants. As healthcare providers increasingly seek to minimize invasive procedures, the demand for transcutaneous bilirubinometers is expected to grow. Additionally, advancements in technology have led to the development of more accurate and reliable transcutaneous devices that enhance diagnostic efficacy while ensuring patient comfort, further propelling market growth in this segment.

Benchtop Bilirubinometer:

Benchtop bilirubinometers are designed for use in clinical laboratories and hospitals, providing precise bilirubin measurements through blood samples. These devices are often equipped with advanced features, such as automated measurement and integrated data management systems, making them suitable for high-throughput testing environments. The growing prevalence of liver diseases and other conditions associated with elevated bilirubin levels is driving the demand for benchtop devices. Healthcare facilities favor benchtop bilirubinometers due to their accuracy and ability to provide comprehensive diagnostic information. Furthermore, innovations aimed at enhancing user experience and operational efficiency are expected to foster market growth within this product segment.

Handheld Bilirubinometer:

Handheld bilirubinometers are compact, portable devices that allow for easy bilirubin level assessment in various settings, including outpatient clinics and home care environments. These devices are particularly advantageous for on-the-go testing, enabling healthcare providers to deliver immediate results without the need for a laboratory. The increasing focus on patient-centric care and convenience is significantly boosting the adoption of handheld bilirubinometers. Moreover, advancements in technology have led to improved accuracy and ease of use, making these devices more reliable for clinicians. The growth of telemedicine and at-home patient monitoring further supports the demand for handheld units, promoting their presence in the bilirubinometer market.

Biliblanket Meter:

The biliblanket meter is a specialized device used in conjunction with phototherapy treatment for neonatal jaundice. This type of bilirubinometer measures the effectiveness of phototherapy by assessing bilirubin levels while infants are under treatment. As the incidence of neonatal jaundice continues to rise, the demand for biliblanket meters is expected to grow. These devices play a crucial role in monitoring treatment progress and facilitating timely medical interventions. The integration of biliblanket meters within neonatal care units ensures enhanced patient safety and optimal treatment outcomes. Ongoing advancements in technology are likely to improve the accuracy and usability of these devices, further supporting their growth in the market.

Others:

The "Others" segment includes various bilirubin measurement devices that may not fit into the major categories mentioned above. This can encompass innovative devices developed for specific or niche applications, including research and specialized clinical settings. The demand for these unique products is driven by the continuous evolution of medical technology and the need for specialized solutions in diverse healthcare environments. As research into bilirubin levels and their implications for health continues to expand, it is likely that new product types will emerge, contributing to the overall growth of the bilirubinometer market.

By Application

Hospitals:

Hospitals represent a significant application segment for bilirubinometers, given their extensive use in diagnosing and managing neonatal jaundice among infants. In hospital settings, the availability of advanced bilirubin measurement technology is critical for ensuring timely and accurate assessments. The high patient volume in hospitals, combined with the need for immediate diagnostic capabilities, drives the demand for both invasive and non-invasive bilirubinometers. Hospitals increasingly prioritize patient safety and care quality, leading to investments in cutting-edge diagnostic tools. Additionally, the integration of bilirubinometers into the hospital workflow enhances efficiency and facilitates better clinical decision-making, making this segment a crucial component of the overall market landscape.

Clinics:

Clinics are another vital application area for bilirubinometers, particularly in pediatric and family practice settings. Pediatric clinics often encounter cases of neonatal jaundice and require reliable diagnostic tools to assess bilirubin levels efficiently. The flexibility and convenience offered by portable and handheld bilirubinometers make them ideal for clinic use, where immediate results are often necessary. Clinics benefit from the ability to provide timely interventions, improving patient outcomes while minimizing the need for hospital referrals. The increasing focus on preventive healthcare and early diagnosis in outpatient settings is expected to bolster the demand for bilirubinometers in clinics, contributing to the growth of this market segment.

Neonatal Intensive Care Units:

Neonatal Intensive Care Units (NICUs) represent a specialized application area for bilirubinometers, given the high incidence of jaundice among premature and critically ill infants. In NICUs, accurate and rapid bilirubin measurement is essential for monitoring the health of vulnerable patients. The increasing complexity of neonatal care necessitates the use of sophisticated bilirubin measurement devices that can provide precise readings in real-time. As the demand for specialized neonatal care continues to rise, the market for bilirubinometers tailored for NICUs is expected to expand. The emphasis on reducing the risks associated with invasive testing enhances the appeal of non-invasive bilirubinometers in these settings, driving further growth in this application segment.

Others:

The "Others" segment encompasses additional applications for bilirubinometers, which may include research institutions, home healthcare settings, and mobile health initiatives. These applications are increasingly relevant as healthcare continues to evolve, with a focus on patient-centric approaches and the integration of technology into care delivery. The demand for bilirubinometers in research settings often relates to studies on bilirubin metabolism and its effects on health, encouraging innovation and development in this market. In home healthcare, portable bilirubinometers enable parents and caregivers to monitor bilirubin levels in infants, facilitating timely interventions without the need for hospital visits. As diverse applications for bilirubinometers expand, this segment is poised for growth within the overall market.

By Distribution Channel

Online Stores:

Online stores have become a significant distribution channel for bilirubinometers, driven by the rising trend of e-commerce in the healthcare sector. The convenience of online shopping allows healthcare professionals and institutions to access a broader range of products, including bilirubinometers, from the comfort of their facilities or homes. Online platforms often provide detailed product information, user reviews, and competitive pricing, making it easier for buyers to make informed purchasing decisions. The COVID-19 pandemic has further accelerated the shift towards online purchasing, as healthcare providers seek to minimize in-person interactions. This growing acceptance of online channels is expected to boost sales and market penetration for bilirubinometers.

Medical Device Stores:

Medical device stores play a crucial role in the distribution of bilirubinometers, serving as dedicated retail outlets for healthcare professionals and institutions. These stores offer a curated selection of medical devices, including various types of bilirubinometers, ensuring that healthcare providers have access to reliable and high-quality products. The expertise of staff in medical device stores can assist buyers in selecting the most suitable devices for their needs, enhancing customer satisfaction. Additionally, the availability of demonstration units in these stores enables potential buyers to evaluate the functionality and usability of bilirubinometers before making a purchase. As healthcare facilities continue to seek out effective diagnostic tools, the demand for bilirubinometers through medical device stores is likely to remain strong.

Hospitals:

Hospitals are not only key users of bilirubinometers but also significant distribution channels for these devices. Hospital procurement departments often directly source bilirubinometers from manufacturers or authorized distributors to ensure they receive high-quality, reliable products. The purchasing decisions made by hospitals are influenced by factors such as product efficacy, supplier reputation, and cost-effectiveness. Consequently, the volume of bilirubinometers procured by hospitals contributes significantly to overall market growth. Furthermore, as hospitals seek to enhance their neonatal care capabilities, investments in advanced bilirubin measurement technologies will likely continue to rise, reinforcing their position as a vital distribution channel.

Others:

The "Others" distribution channel segment includes various alternative avenues for acquiring bilirubinometers, such as direct sales from manufacturers, trade shows, and international distributors. Direct sales allow manufacturers to engage with healthcare providers personally, fostering relationships and ensuring customer support. Trade shows provide an opportunity for healthcare professionals to explore the latest innovations in bilirubin measurement technology and establish connections with suppliers. International distributors play a significant role in reaching markets where local availability may be limited. Together, these alternative channels contribute to a diversified distribution landscape, enhancing access to bilirubinometers across various healthcare settings.

By User

Pediatricians:

Pediatricians are one of the primary users of bilirubinometers, as they are often the first point of contact for infants exhibiting signs of jaundice. The ability to quickly and accurately assess bilirubin levels is crucial for pediatricians in determining the appropriate course of action for affected infants. These medical professionals rely on bilirubinometers to provide timely diagnoses, which can significantly impact treatment outcomes. The growing awareness of neonatal jaundice and its potential complications has prompted pediatricians to prioritize the use of advanced bilirubin measurement technologies. As pediatric practices continue to evolve, the demand for bilirubinometers among pediatricians is expected to increase substantially.

Neonatologists:

Neonatologists, specialists in the care of newborns, particularly preterm and critically ill infants, are significant users of bilirubinometers. In neonatal intensive care settings, the ability to monitor bilirubin levels accurately and frequently is essential for ensuring the well-being of vulnerable patients. Neonatologists depend on advanced bilirubin measurement tools to guide treatment decisions, particularly in the management of neonatal jaundice. The increasing complexity of neonatal care necessitates the implementation of reliable and precise bilirubin measurement devices, further amplifying the role of bilirubinometers in this specialty. As the focus on improving neonatal outcomes continues, the demand for bilirubinometers within this user category is projected to grow.

Nurses:

Nurses play a pivotal role in the monitoring and management of bilirubin levels in infants, particularly in hospital and outpatient settings. They are often responsible for performing initial assessments and administering treatments based on bilirubin measurements. The integration of bilirubinometers into nursing workflows enhances the efficiency of care delivery and allows for timely interventions. Given their proximity to patient care, nurses are crucial advocates for the adoption of advanced bilirubin measurement technologies that can streamline processes and improve outcomes. As the nursing profession continues to evolve, the demand for bilirubinometers that meet their clinical needs is expected to rise significantly.

Others:

The "Others" user segment includes various healthcare professionals and caregivers who may utilize bilirubinometers in their practice. This includes nurse practitioners, midwives, and home healthcare providers who play a role in monitoring bilirubin levels among infants. The demand for bilirubinometers among these users is driven by the increasing emphasis on early detection and intervention for neonatal jaundice. Furthermore, as home healthcare becomes more prevalent, the need for portable and easy-to-use bilirubinometers is likely to grow. This diverse range of users contributes to the overall market expansion, highlighting the importance of bilirubinometers across various healthcare delivery models.

By Region

The regional analysis of the bilirubinometer market reveals significant variation in demand and growth potential across different areas. North America holds a dominant share of the market, primarily driven by advanced healthcare infrastructure, a high prevalence of neonatal jaundice, and increasing investments in pediatric care. The region's market is expected to grow at a CAGR of 6.2% over the forecast period, reflecting ongoing innovations in bilirubin measurement technologies and the rising emphasis on early diagnosis and treatment. Moreover, government initiatives aimed at improving neonatal health outcomes further support market growth in North America. This robust landscape positions the region as a key player in the global bilirubinometer market.

In contrast, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by a rapidly increasing population, rising healthcare expenditure, and heightened awareness of neonatal health issues. The market in Asia Pacific is projected to grow at a CAGR of 7.5%, reflecting a strong demand for bilirubinometers in both urban and rural healthcare settings. Additionally, the expansion of healthcare facilities and the implementation of government policies focused on improving maternal and child health serve to bolster market prospects in this region. Other regions, such as Europe and Latin America, are also expected to contribute to market growth, albeit at a more moderate pace due to differing healthcare dynamics.

Opportunities

The bilirubinometer market presents numerous opportunities for growth, particularly as healthcare providers continue to seek innovative solutions for diagnosing and managing neonatal jaundice. One of the most significant opportunities lies in the ongoing development of non-invasive bilirubin measurement technologies. As more healthcare facilities recognize the benefits of non-invasive methods—such as reduced discomfort for infants and quicker results—there is a growing demand for portable and user-friendly bilirubinometers. Additionally, the increasing adoption of telemedicine and home healthcare solutions creates new avenues for the distribution and use of bilirubinometers. Manufacturers that focus on developing devices that cater to these evolving care models will likely find success in capturing market share.

Furthermore, strategic partnerships and collaborations between manufacturers, healthcare providers, and research institutions present substantial opportunities to expand the reach and application of bilirubinometers. By working together, stakeholders can leverage their respective expertise to drive innovation and enhance product offerings. Additionally, entering emerging markets with growing healthcare infrastructure provides manufacturers with a chance to establish a foothold in regions where the demand for bilirubinometers is on the rise. Overall, the ongoing evolution of healthcare delivery and the increasing focus on early detection and intervention create a fertile ground for growth within the bilirubinometer market.

Threats

Despite the promising growth prospects, the bilirubinometer market faces several threats that could hinder its expansion. One of the primary challenges is the presence of stringent regulatory requirements for medical devices, which can create barriers to entry for new market players. The complex and lengthy approval processes for medical devices may delay the introduction of innovative products, thereby limiting competition and stifling advancements in technology. Moreover, fluctuations in healthcare budgets, particularly in public healthcare systems, can impact the purchasing decisions of hospitals and clinics, potentially leading to reduced demand for bilirubinometers. Additionally, the increasing prevalence of alternative diagnostic methods may pose a threat to traditional bilirubinometers as healthcare providers seek more cost-effective or efficient solutions.

Another significant threat to the bilirubinometer market is the potential for market saturation as competition increases. As more companies enter the market with similar product offerings, the competitive landscape could become crowded, leading to price wars and reduced profit margins for manufacturers. The rapid pace of technological advancements may also challenge existing companies to keep up with consumer demands for more advanced, accurate, and user-friendly devices. As customer preferences shift toward innovative solutions, manufacturers that fail to adapt may find themselves at a disadvantage. Therefore, navigating these challenges will be crucial for stakeholders aiming to thrive in the evolving bilirubinometer market.

Competitor Outlook

• Philips Healthcare
• Graham-Field Health Products
• Radiometer Medical
• Beckman Coulter
• Microlife Corporation
• Drägerwerk AG
• Koninklijke Philips N.V.
• Boram Medical
• Humares
• Medline Industries
• Ginevri
• American Diagnostic Corporation
• Welch Allyn
• AccuMED Technology
• Charder Electronic Co., Ltd.

The competitive landscape of the bilirubinometer market is characterized by the presence of several key players that are continuously innovating and expanding their product offerings to capture a larger share of the market. Major companies, such as Philips Healthcare and Drägerwerk AG, are investing heavily in research and development to enhance the accuracy and usability of their bilirubinometers. These companies leverage their established brand recognition and extensive distribution networks to maintain a competitive edge. Additionally, some players focus on strategic partnerships and collaborations to broaden their product portfolios and improve market access. For instance, collaborations with healthcare institutions can facilitate the development of custom solutions tailored to specific clinical needs, further strengthening their market position.

Another noteworthy trend within the competitive landscape is the increasing emphasis on technological innovation. Companies like Microlife Corporation and AccuMED Technology are exploring advanced features such as connectivity options for telemedicine applications and cloud-based data management systems. These technological advancements not only enhance the functionality of bilirubinometers but also align with the growing trend of remote patient monitoring. As healthcare providers increasingly adopt digital solutions, manufacturers that prioritize innovation and adaptability will be better positioned to succeed in the evolving market. Furthermore, emerging companies are entering the market with unique value propositions, creating a dynamic competitive environment that encourages continuous improvement and differentiation among products.

In conclusion, the bilirubinometer market is characterized by a diverse range of competitors, each vying for market share through innovation, strategic partnerships, and quality product offerings. Key players such as Beckman Coulter and Graham-Field Health Products are focusing on expanding their global reach and enhancing their product lines to cater to the growing demand for bilirubinometers. As the market continues to evolve, established players must remain vigilant and responsive to emerging trends and shifts in consumer preferences. Overall, the combination of technological advancements, strategic collaborations, and a focus on quality will play a crucial role in shaping the future landscape of the bilirubinometer market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Ginevri
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Humares
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Welch Allyn
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Boram Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Beckman Coulter
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 AccuMED Technology
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Medline Industries
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Radiometer Medical
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Drägerwerk AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Microlife Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Koninklijke Philips N.V.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Charder Electronic Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Graham-Field Health Products
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 American Diagnostic Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bilirubinometer Market, By user
    • 6.1.1 Pediatricians
    • 6.1.2 Neonatologists
    • 6.1.3 Nurses
    • 6.1.4 Others
  • 6.2 Bilirubinometer Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Neonatal Intensive Care Units
    • 6.2.4 Others
  • 6.3 Bilirubinometer Market, By Product Type
    • 6.3.1 Transcutaneous Bilirubinometer
    • 6.3.2 Benchtop Bilirubinometer
    • 6.3.3 Handheld Bilirubinometer
    • 6.3.4 Biliblanket Meter
    • 6.3.5 Others
  • 6.4 Bilirubinometer Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Medical Device Stores
    • 6.4.3 Hospitals
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bilirubinometer Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bilirubinometer market is categorized based on

By Product Type

• Transcutaneous Bilirubinometer
• Benchtop Bilirubinometer
• Handheld Bilirubinometer
• Biliblanket Meter
• Others

By Application

• Hospitals
• Clinics
• Neonatal Intensive Care Units
• Others

By Distribution Channel

• Online Stores
• Medical Device Stores
• Hospitals
• Others

By user

• Pediatricians
• Neonatologists
• Nurses
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Philips Healthcare
• Graham-Field Health Products
• Radiometer Medical
• Beckman Coulter
• Microlife Corporation
• Drägerwerk AG
• Koninklijke Philips N.V.
• Boram Medical
• Humares
• Medline Industries
• Ginevri
• American Diagnostic Corporation
• Welch Allyn
• AccuMED Technology
• Charder Electronic Co., Ltd.